Coexistence of familial Mediterranean fever and rheumatoid arthritis

REFERENCES

• El-Shanti H, Majeed HA, El-Khateeb M. Familial Mediterranean fever in Arabs. Lancet. 2006;367:1016–24.
   Google Scholar
• Tsuchiya-Suzuki A, Yazaki M, Nakamura A, Yamazaki K, Ag-ematsu K, Matsuda M, et al. Clinical and genetic features of familial Mediterranean fever in Japan. J Rheumatol. 2009;36:1671–6.
   Google Scholar
• Fonnesu C, Cerquaglia C, Giovinale M, Curigliano V, Verrecchia E, de Socio G, et al. Familial Mediterranean fever: a review for clinical management. Joint Bone Spine. 2009;76:227–33.
   Google Scholar
• Heller H, Gafni J, Michaeli D, Shahin N, Sohar E, Ehrlich G, et al. The arthritis of familial Mediterranean fever (FMF). Arthr Rheum. 1966;9:1–17.
   PubMed Web of Science ®Google Scholar
• Sneh E, Pras M, Michaeli D, Shanin N, Gafni J. Protracted arthritis in familial Mediterranean fever. Rheumatol Rehabil. 1977;16:102–6.
   Google Scholar
• Migita K, Torigoshi T, Motokawa S, Ito M, Miyashita T, Izumi Y, et al. Protracted synovitis without systemic manifestations in familial Mediterranean fever (FMF). Clin Exp Rheumatol. 2010;28:S99.
   PubMedGoogle Scholar
• Turan Y, endur OF, Berkit IK. Coexistence of familial Medi-terranean fever and rheumatoid arthritis in A Case. Turk J Rheumatol. 2010;25:44–6.
   Google Scholar
• Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. Rheumatoid arthritis classification criteria: an Ameri-can College of Rheumatology/European League Against Rheu-matism collaborative initiative. Arthr Rheum. 2010;62:2569–81.
   PubMed Web of Science ®Google Scholar
• Langevitz P, Livneh A, Zemer D, Shemer J, Pras M. Seronegative spondyloarthropathy in familial Mediterranean fever. Semin Arthr Rheum. 1997;27:67–72.
   PubMed Web of Science ®Google Scholar
• Uthman I, Hajj-Ali RA, Arayssi T, Masri AF, Nasr F. Arthritis in familial Mediterranean fever. Rheumatol Int. 2001;20:145–8.
   PubMed Web of Science ®Google Scholar
• Garcia-Gonzalez A, Weisman MH. The arthritis of familial Mediterranean fever. Semin Arthr Rheum. 1992;22:139–50.
   PubMed Web of Science ®Google Scholar
• Herness D, Makin M. Articular damage in familial Mediterranean fever. Report of four cases. J Bone Joint Surg Am. 1975;57:265–7.
   PubMedGoogle Scholar
• Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthr Rheum. 2009;61:772–8.
   PubMed Web of Science ®Google Scholar
• Karatay S, Yildirim K, Erdal A, Uzkeser H, Erdem FH, Yanmaz V. Anti-cyclic citrullinated peptide antibodies are not associated with familial Mediterranean fever. J Back Musculoskelet Rehabil. 2010;23:21–3.
   PubMedGoogle Scholar
• Ceri M, Unverdi S, Altay M, Ureten K, Oztürk MA, amen N, et al. Anti-cyclic citrullinated peptides positivity rate in patients with familial Mediterranean fever. Clin Exp Rheumatol. 2010;28:S58–61.
   Google Scholar
• Majeed HA, Rawashdeh M. The clinical patterns of arthritis in children with familial Mediterranean fever. QJM. 1997;90:37–43.
   PubMed Web of Science ®Google Scholar
• Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthr Rheum. 1997;40:1879–85.
   PubMed Web of Science ®Google Scholar
• Masters SL, Simon A, Akentijevich I, Kastner DL. Horror autoinfiammaticus: the molecular pathophysiology of autoin-fiammatory disease. Annu Rev Immunol. 2009;27:621–68.
   PubMed Web of Science ®Google Scholar
• Chae JJ, Aksentijevich I, Kastner DL. Advances in the under-standing of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol. 2009;146:467–78.
   Google Scholar
• Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-lbeta production. Proc Natl Acad Sci USA. 2006;103: 9982–7.
   Google Scholar
• Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a sys-tematic review. J Rheumatol. 2009;36:1118–25.
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Peleg H, Aamar S, Heyman SN. The spectrum of MEFV clinical presentations-is it familial Mediterranean fever only? Rheumatology (Oxford). 2009;48:1455–9.
   Google Scholar
• Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M, et al. Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis. 2005;64:1009–14.
   PubMed Web of Science ®Google Scholar
• Gaujoux-Viala C, Smolen JS, Landewé R, Dougados M, Kvien TK, Mola EM, et al. Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheu-matic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2010;69:1004–9.
   Google Scholar
• Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med. 1967;43:227–53.
   PubMed Web of Science ®Google Scholar
• Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in preventing attacks of familial meditenanean fever. N Engl J Med. 1974;291:932–4.
   PubMed Web of Science ®Google Scholar
• Sève P, Stankovic K, Broussolle C. Effectiveness of colchicine in a case of recurrent compressive rheumatoid pericarditis. Rheu-matol Int. 2005;25:558–61.
   Google Scholar
• Migita K, Ida H, Moriuchi H, Agematsu K. Clinical Relevance of MEFV Gene Mutations in Japanese Patients with Unexplained Fever. J Rheumatol. 2012;39:875–7.
   PubMed Web of Science ®Google Scholar
• Shimizu M, Tone Y, Toga A, Yokoyama T, Wada T, Toma T, et al. Colchicine-responsive chronic recurrent multifocal osteo-myelitis with MEFV mutations: a variant of familial Mediterra-nean fever? Rheumatology. 2010;49:2221-3.
   Google Scholar